40th Annual J.P. Morgan Healthcare Conference Mick Farrell - CEO January 10, 2022 Presentation of financial information & forward-looking statements Historical financial and operating data in this presentation reflect the consolidated results of ResMed Inc., its subsidiaries, and its legal entities, for the periods indicated. This presentation includes financial information prepared in accordance with accounting principles generally accepted in the United States, or GAAP, as well as other financial measures ...

ResMed Inc. (NYSE:RMD) Q1 2022 Earnings Conference Call October 28, 2021 4:30 PM ET Company Participants Amy Wakeham - Vice President, Investor Relations & Corporate Communications Mick Farrell - Chief Executive Officer Brett Sandercock - Chief Financial Officer Rob Douglas - President and Chief Operating Officer Jim Hollingshead - President, Sleep & Respiratory Care business Conference Call Participants Matthew Mishan - KeyBanc Chris Cooper - Goldman Sachs David Low - JPMorgan Suraj Kalia - Oppenheimer Gre ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 ______________________________________________________________________________________________ FORM 10-Q ______________________________________________________________________________________________ (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2021 ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 ...

ResMed Investor Day September 8, 2021 Forward Looking Statements Historical financial and operating data in this presentation reflect the consolidated results of ResMed Inc., its subsidiaries, and its legal entities, for the periods indicated. This presentation includes financial information prepared in accordance with accounting principles generally accepted in the United States, or GAAP, as well as other financial measures referred to as non-GAAP. The non-GAAP financial measures in this presentation, whic ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ______________________________________________________________________________________________ FORM 10-K ______________________________________________________________________________________________ [X] ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended June 30, 2021 Commission file number: 001-15317 _____________________________________________________________________________ ...

ResMed Inc. (NYSE:RMD) Q4 2021 Earnings Conference Call August 5, 2021 4:30 PM ET Company Participants Amy Wakeham - Vice President of Investor Relations and Corporate Communications Mick Farrell - Chief Executive Officer Brett Sandercock - Chief Financial Officer James Hollings - President, Sleep and Respiratory Care Business Rob Douglas - Chief Operating Officer Conference Call Participants John Deakin-Bell - Citi Investment Research Dan Hurren - MST Marquee David Bailey - Macquarie Sean Laaman - Morgan S ...

Q4 FY2021 Earnings August 5, 2021 Presentation of financial information & forward-looking statements Historical financial and operating data in this presentation reflect the consolidated results of ResMed Inc., its subsidiaries, and its legal entities, for the periods indicated. This presentation includes financial information prepared in accordance with accounting principles generally accepted in the United States, or GAAP, as well as other financial measures referred to as non-GAAP. The non-GAAP financial ...

Q3 FY2021 Earnings April 29, 2021 Presentation of financial information & forward-looking statements Historical financial and operating data in this presentation reflect the consolidated results of ResMed Inc., its subsidiaries, and its legal entities, for the periods indicated. This presentation includes financial information prepared in accordance with accounting principles generally accepted in the United States, or GAAP, as well as other financial measures referred to as non-GAAP. The non-GAAP financial ...

ResMed Inc. (NYSE:RMD) Q3 2021 Earnings Conference Call April 29, 2021 4:30 PM ET Company Participants Amy Wakeham - Vice President of Investor Relations and Corporate Communications Mick Farrell - Chief Executive Officer Brett Sandercock - Chief Financial Officer David Pendarvis - Secretary and Chief Administrative Officer James Hollings - President, Sleep and Respiratory Care Business Rob Douglas - Chief Operating Officer Conference Call Participants Lyanne Harrison - Bank of America Gretel Janu - Credit ...

For the transition period from _______to _______ Commission File Number: 001-15317 ______________________________________________________________________________________________ ResMed Inc. UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 ______________________________________________________________________________________________ FORM 10-Q ______________________________________________________________________________________________ (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 ...